Double Medical Technology Stock Net Income
| 002901 Stock | 33.19 0.42 1.28% |
Double Medical Technology fundamentals help investors to digest information that contributes to Double Medical's financial success or failures. It also enables traders to predict the movement of Double Stock. The fundamental analysis module provides a way to measure Double Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Double Medical stock.
| Last Reported | Projected for Next Year | ||
| Net Income Applicable To Common Shares | 774.3 M | 443.1 M | |
| Net Income From Continuing Ops | 86.3 M | 82 M | |
| Net Income | 59 M | 56 M |
Double | Net Income |
Double Medical Technology Company Net Income Analysis
Double Medical's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current Double Medical Net Income | 58.97 M |
Most of Double Medical's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Double Medical Technology is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Double Net Income Applicable To Common Shares
Net Income Applicable To Common Shares |
|
Based on the recorded statements, Double Medical Technology reported net income of 58.97 M. This is 82.72% lower than that of the Health Care Equipment & Supplies sector and 75.23% lower than that of the Health Care industry. The net income for all China stocks is 89.67% higher than that of the company.
Double Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Double Medical's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Double Medical could also be used in its relative valuation, which is a method of valuing Double Medical by comparing valuation metrics of similar companies.Double Medical is currently under evaluation in net income category among its peers.
Double Fundamentals
| Return On Equity | 0.0717 | ||||
| Return On Asset | 0.0243 | ||||
| Profit Margin | 0.10 % | ||||
| Operating Margin | 0.24 % | ||||
| Current Valuation | 12.85 B | ||||
| Shares Outstanding | 414.02 M | ||||
| Shares Owned By Insiders | 86.31 % | ||||
| Shares Owned By Institutions | 3.45 % | ||||
| Price To Book | 4.34 X | ||||
| Price To Sales | 7.05 X | ||||
| Revenue | 1.53 B | ||||
| Gross Profit | 1.68 B | ||||
| EBITDA | 282.18 M | ||||
| Net Income | 58.97 M | ||||
| Total Debt | 316.13 M | ||||
| Book Value Per Share | 7.75 X | ||||
| Cash Flow From Operations | 73.86 M | ||||
| Earnings Per Share | 0.48 X | ||||
| Target Price | 41.0 | ||||
| Number Of Employees | 4.03 K | ||||
| Beta | 0.14 | ||||
| Market Capitalization | 13.66 B | ||||
| Total Asset | 4.64 B | ||||
| Retained Earnings | 1.28 B | ||||
| Working Capital | 2 B | ||||
| Annual Yield | 0.01 % | ||||
| Net Asset | 4.64 B | ||||
| Last Dividend Paid | 0.25 |
About Double Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Double Medical Technology's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Double Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Double Medical Technology based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Double Stock
Double Medical financial ratios help investors to determine whether Double Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Double with respect to the benefits of owning Double Medical security.